Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Onconetix Inc (ONCO)

Onconetix Inc (ONCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,239
  • Shares Outstanding, K 1,555
  • Annual Sales, $ 2,520 K
  • Annual Income, $ -58,690 K
  • EBIT $ -7 M
  • EBITDA $ 5 M
  • 60-Month Beta 3.42
  • Price/Sales 0.88
  • Price/Cash Flow N/A
  • Price/Book 0.66

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3700 +6.57%
on 12/29/25
3.2200 -54.66%
on 12/10/25
-1.3200 (-47.48%)
since 11/28/25
3-Month
1.3700 +6.57%
on 12/29/25
4.1900 -65.16%
on 10/09/25
-1.6500 (-53.05%)
since 09/30/25
52-Week
1.3700 +6.57%
on 12/29/25
179.3500 -99.19%
on 12/31/24
-35.6850 (-96.07%)
since 12/30/24

Most Recent Stories

More News
Onconetix Completes PIPE Financing Transaction

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

ONCO : 1.4400 (unch)
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

CINCINNATI, OH, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the “Company”) a commercial stage biotechnology company focused on the research, development and...

ONCO : 1.4400 (unch)
Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

CINCINNATI, OH & FORT LEE, NJ, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO), a commercial-stage biotechnology company focused on innovative solutions for men's health and oncology,...

ONCO : 1.4400 (unch)
Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

CINCINNATI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the “Company”) a commercial stage biotechnology company focused on the research, development and commercialization...

ONCO : 1.4400 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ONCO, WAT, XAGE on Behalf of Shareholders

NEW YORK , July 18, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WAT : 381.13 (-1.03%)
ONCO : 1.4400 (unch)
XAGE : 0.3815 (+8.97%)
ONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Onconetix, Inc. (NASDAQ: ONCO) and Ocuvex Therapeutics, Inc. is fair to Onconetix shareholders. Upon completion of...

ONCO : 1.4400 (unch)
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

CINCINNATI, July 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company...

ONCO : 1.4400 (unch)
Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

ONCO : 1.4400 (unch)
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

ONCO : 1.4400 (unch)
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

ONCO : 1.4400 (unch)

Business Summary

Onconetix Inc. is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. Onconetix Inc., formerly known as Blue Water Biotech Inc., is based in CINCINNATI.

See More

Key Turning Points

3rd Resistance Point 1.6167
2nd Resistance Point 1.5533
1st Resistance Point 1.4967
Last Price 1.4400
1st Support Level 1.3767
2nd Support Level 1.3133
3rd Support Level 1.2567

See More

52-Week High 179.3500
Fibonacci 61.8% 111.3616
Fibonacci 50% 90.3600
Fibonacci 38.2% 69.3584
Last Price 1.4400
52-Week Low 1.3700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar